Guaman-Bautista Linda P, Moreta-Urbano Erick, Oña-Arias Claudia G, Torres-Arias Marbel, Kyriakidis Nikolaos C, Malcı Koray, Jonguitud-Borrego Nestor, Rios-Solis Leonardo, Ramos-Martinez Espiridion, López-Cortés Andrés, Barba-Ostria Carlos
Centro de Investigación Biomédica, Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE, Quito 170147, Ecuador.
Immunology and Virology Laboratory, Department of Life Science and Agriculture, Universidad de las Fuerzas Armadas, Quito 171103, Ecuador.
Diagnostics (Basel). 2021 Oct 26;11(11):1981. doi: 10.3390/diagnostics11111981.
The COVID-19 pandemic has had an enormous impact on economies and health systems globally, therefore a top priority is the development of increasingly better diagnostic and surveillance alternatives to slow down the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In order to establish massive testing and contact tracing policies, it is crucial to have a clear view of the diagnostic options available and their principal advantages and drawbacks. Although classical molecular methods such as RT-qPCR are broadly used, diagnostic alternatives based on technologies such as LAMP, antigen, serological testing, or the application of novel technologies such as CRISPR-Cas for diagnostics, are also discussed. The present review also discusses the most important automation strategies employed to increase testing capability. Several serological-based diagnostic kits are presented, as well as novel nanotechnology-based diagnostic methods. In summary, this review provides a clear diagnostic landscape of the most relevant tools to track COVID-19.
新冠疫情对全球经济和卫生系统产生了巨大影响,因此,当务之急是开发越来越好的诊断和监测手段,以减缓严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的传播。为了制定大规模检测和接触者追踪政策,清楚了解现有的诊断选项及其主要优缺点至关重要。尽管诸如逆转录定量聚合酶链反应(RT-qPCR)等经典分子方法被广泛应用,但基于环介导等温扩增技术(LAMP)、抗原、血清学检测等技术的诊断方法,或诸如用于诊断的CRISPR-Cas等新技术的应用也在讨论之中。本综述还讨论了为提高检测能力而采用的最重要的自动化策略。介绍了几种基于血清学的诊断试剂盒以及基于新型纳米技术的诊断方法。总之,本综述提供了一份清晰的用于追踪新冠病毒的最相关工具的诊断概况。